SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- To help more patients with rheumatoid arthritis (RA), Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, and Family Medicine Specialists (FMS), a ...
While cholesterol levels are commonly used to assess heart disease risk, research shows that another blood marker—high-sensitivity C-reactive protein (hs-CRP)—may offer even more powerful insight, ...
Cardiac magnetic resonance imaging (MRI) is an appropriate non-invasive procedure for functional diagnostics in patients who, ...
Deepak L. Bhatt, MD, MPH: Let me turn now to Dr Navar to discuss what I think is an important part of the discussion. She’s done a lot of work on this. How do we actually estimate patients’ risk for ...
Global diagnostics company Randox Laboratories has unveiled an innovative new test for the risk assessment of cardiovascular disease at this year's AACC Clinical Lab Expo in Anaheim, California. The ...
Traditional risk assessment for cardiovascular disease (CVD) uses several factors to compile scores to formulate an estimated CVD risk, used by clinicians to advise their patients. Coronary artery ...
The final gapfill payment rate for both the Epi+Gen CHD™ and PrecisionCHD™ tests is higher at $854 compared to the preliminary gapfill payment rates of $350 for Epi+Gen CHD™ and $684.76 for ...
From young people dying suddenly of heart attacks to a 50% surge in cardiac medication sales in India over the past five years, cardiovascular disease (CVD) is clearly on the rise. Cardiovascular ...